nejm semaglutide heart failure SELECT Trial obesity #clinicaltrials #medicalresearch | NEJM

Choose whatever day and time works for your schedule and stick with it consistently

Its ability to reverse established cirrhosis remains unproven, and evidence of direct antifibrotic activity is still limited, suggesting that benefits in advanced disease may be largely metabolic rather than fibrosis-targeted

Reputable suppliers should also comply with relevant regulatory requirements and provide transparent information about their products and processes

It does not require injections and can easily be incorporated into daily routines

Population pharmacokinetic analysis showed that the apparent oral clearance of empagliflozin decreased, with a decrease in eGFR leading to an increase in drug exposure